Emergent BioSolutions EBS
NYSE EBS
$6.76 +0.21 (+3.21%)
At close: Sep 22, 2026 · 4:00 PM EDT

Emergent BioSolutions (EBS) Cash from Operations Growth (3y) (2013 - 2026)

Analysis

Emergent BioSolutions (EBS) Cash from Operations Growth (3y) (2013 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Ops. Growth (3y) (Qtr)
1 Johnson & Johnson 649.47 Bn 628.71 Bn 17.26 Bn 27.24%
2 AbbVie 467.46 Bn 460.93 Bn 12.70 Bn -18.38%
3 Merck 369.31 Bn 362.22 Bn 12.21 Bn 13.18%
4 Novartis Ag 269.03 Bn 261.74 Bn 11.24 Bn 18.04%
5 Pfizer 158.11 Bn 146.71 Bn 10.94 Bn 39.10%
6 Bristol Myers Squibb 127.96 Bn 116.89 Bn 9.25 Bn 21.60%
7 Sanofi 51.83 Bn 44.86 Bn 10.79 Bn 56.97%
8 BeOne Medicines 41.33 Bn 36.23 Bn 1.53 Bn 52.90%
9 Revolution Medicines 41.30 Bn 41.30 Bn - -
10 Emergent BioSolutions 335.50 Mn 194.60 Mn 137.20 Mn 35.55%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 35.55%
Mar 31, 2026 43.15%
Dec 31, 2025 -5.75%
Sep 30, 2025 68.56%
Jun 30, 2025 106.62%
Mar 31, 2025 33.04%
Dec 31, 2024 -30.91%
Sep 30, 2024 109.57%
Jun 30, 2024 53.25%
Mar 31, 2024 -142.58%
Dec 31, 2023 -49.28%
Sep 30, 2023 -17.07%
Jun 30, 2023 -42.51%
Mar 31, 2023 -73.06%
Dec 31, 2022 -8.74%
Sep 30, 2022 -187.93%
Jun 30, 2022 24.19%
Mar 31, 2022 -33.06%
Dec 31, 2021 58.46%
Sep 30, 2021 -54.22%
API Access

Emergent BioSolutions Cash from Operations Growth (3y) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-operations-growth-3y&ticker=EBS&period=max&api_key=YOUR_API_KEY